COMP <GO>
ASMB vs AVTX // NET PROFIT MARGIN
Assembly Biosciences Inc. (NASDAQ) VS. Avalo Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: ASMB 9
— AVTX 0
▲ NET PROFIT MARGIN LEADER: ASMB
LAST: $20.86 (+1.41%) • MKT CAP: $424.7M
net-margins
-8.50%
LAST: $7.44 (+4.49%) • MKT CAP: $399.0M
net-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASMB VS. AVTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ASMB | AVTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -6.50% | -35.00% | +28.50 | ASMB | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -9.69% | -12.90% | +3.21 | ASMB | /fcf-yield <GO> |
| Operating Margin | -16.80% | -60.00% | +43.20 | ASMB | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -8.50% | -60.00% | +51.50 | ASMB | /net-margins <GO> |
| Revenue Growth (YoY) | 153.50% | -65.00% | +218.50 | ASMB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.57 | 0.66 | +0.91 | ASMB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | ASMB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.8 | 25.3 | +16.50 | ASMB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $424.7M | $399.0M | $25.7M | ASMB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ASMB REV | AVTX REV | ASMB GROSS % | AVTX GROSS % | ASMB FCF | AVTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $72.3M | $59.0K | — | — | -$41.2M | -$51.5M |
| FY 2024 | $28.5M | $441.0K | — | — | -$51.1M | -$49.1M |
| FY 2023 | $0 | $1.9M | — | — | $22.7M | -$30.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASMB // BETA —
AVTX // BETA —